USANA Health Sciences, Inc.
USNA
$30.02
$0.521.76%
NYSE
| 03/29/2025 | 12/28/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.82% | 6.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.82% | 6.69% | |||
| Cost of Revenue | 36.03% | -1.79% | |||
| Gross Profit | 12.59% | 8.76% | |||
| SG&A Expenses | 8.73% | 14.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.86% | 11.26% | |||
| Operating Income | 90.88% | -47.38% | |||
| Income Before Tax | 60.50% | -43.95% | |||
| Income Tax Expenses | 25.30% | -25.70% | |||
| Earnings from Continuing Operations | 107.18% | -57.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 473.33% | -- | |||
| Net Income | 111.09% | -58.01% | |||
| EBIT | 90.88% | -47.38% | |||
| EBITDA | 96.66% | -36.31% | |||
| EPS Basic | 111.75% | -58.08% | |||
| Normalized Basic EPS | 63.46% | -44.29% | |||
| EPS Diluted | 114.25% | -58.87% | |||
| Normalized Diluted EPS | 63.13% | -44.27% | |||
| Average Basic Shares Outstanding | -0.29% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.10% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||